More ImpediMed Limited news
ImpediMed LimitedASX: IPD

S&P DJI Announces March 2023 Quarterly Rebalance

Mar 3, 2023 at 6:24 AM EST · Issued by ImpediMed Limited

Filed with ASX · Mar 3, 2023 at 6:24 AM EST · 8 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2023-quarterly-rebalance-65

Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29↗

ImpediMed Limited on 6ix

Story so far

  • S&P DJI Announces March 2022 Quarterly RebalanceMar 4, 2022

Earlier from ImpediMed

  • Appendix 4C & Quarterly Activities Report - Dec-22 QtrJan 29, 2023
  • New Version of NCCN Guidelines for Breast CancerJan 29, 2023
  • ImpediMed Announces Appointment of Managing Director and CEONov 28, 2022
  • ImpediMed Announces Management ReorganisationNov 21, 2022
  • AstraZeneca Further Extends Clinical Trial ContractNov 9, 2022

Later from ImpediMed

  • NCCN Guidelines Now Recommend Bioimpedance SpectroscopyMar 26, 2023
  • Appendix 4C & Quarterly Activities Report - Mar-23 QtrApr 16, 2023
  • SOZO Pro Achieves Clearance by U.S. FDAMay 4, 2023
  • Trading HaltMay 17, 2023
  • Placement and SPP NotificationMay 18, 2023
All ImpediMed news releases↗

Follow ImpediMed into a list and get an email when it puts out news.

Follow ImpediMed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer